Thomas P. Loughran

Hematology

1240 Lee St
Charlottesville, VA 22908

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 139 publications

The Oncology Research Information Exchange Network (ORIEN) - Building a real-world collaborative, patient-driven infrastructure for discovery research and precision oncology.

The Oncology Research Information Exchange Network (ORIEN) - Building a real-world collaborative, patient-driven infrastructure for discovery research and precision oncology.

Journal: Research square

Published: June 12, 2026

The Oncology Research Information Exchange Network (ORIEN) - Building a Real-World Collaborative, Patient-driven Infrastructure for Discovery Research and Precision Oncology.

The Oncology Research Information Exchange Network (ORIEN) - Building a Real-World Collaborative, Patient-driven Infrastructure for Discovery Research and Precision Oncology.

Journal: Research square

Published: June 12, 2026

Anti-PAD4 antibodies link autoimmunity to PAD4 with CTL-associated rheumatoid arthritis.

Anti-PAD4 antibodies link autoimmunity to PAD4 with CTL-associated rheumatoid arthritis.

Journal: Annals of the rheumatic diseases

Published: December 23, 2025

Acid ceramidase inhibition enhances BCL-2 targeting in venetoclax-resistant acute myeloid leukemia.

Acid ceramidase inhibition enhances BCL-2 targeting in venetoclax-resistant acute myeloid leukemia.

Journal: Blood neoplasia

Published: September 03, 2025

Pharmacological blockade of rho kinase enhances venetoclax responses in translational models of acute myeloid leukemia.

Pharmacological blockade of rho kinase enhances venetoclax responses in translational models of acute myeloid leukemia.

Journal: Haematologica

Published: August 25, 2025

International Consensus Criteria for the Diagnosis, Treatment Initiation, and Response Assessment for T-LGL Leukemia.

International Consensus Criteria for the Diagnosis, Treatment Initiation, and Response Assessment for T-LGL Leukemia.

Journal: Blood

Published: June 25, 2025

Acid ceramidase inhibition enhances BCL-2 targeting in venetoclax-resistant acute myeloid leukemia via a cytotoxic integrated stress response.

Acid ceramidase inhibition enhances BCL-2 targeting in venetoclax-resistant acute myeloid leukemia via a cytotoxic integrated stress response.

Journal: bioRxiv : the preprint server for biology

Published: June 12, 2025

Acute myeloid leukemia mitochondria hydrolyze ATP to support oxidative metabolism and resist chemotherapy.

Acute myeloid leukemia mitochondria hydrolyze ATP to support oxidative metabolism and resist chemotherapy.

Journal: Science advances

Published: April 09, 2025

Diagnostic criteria for NK cell large granular lymphocyte leukemia: validation through a multicentric international study.

Diagnostic criteria for NK cell large granular lymphocyte leukemia: validation through a multicentric international study.

Journal: Blood advances

Published: March 17, 2025

Clinical Characteristics, Management, and Hematopoietic Cell Transplantation of Patients with TLR8 Gain-of-Function.

Clinical Characteristics, Management, and Hematopoietic Cell Transplantation of Patients with TLR8 Gain-of-Function.

Journal: Blood advances

Published: February 26, 2025

Clinical characteristics, management, and hematopoietic cell transplantation of patients with TLR8 gain-of-function.

Clinical characteristics, management, and hematopoietic cell transplantation of patients with TLR8 gain-of-function.

Journal: Blood advances

Published: February 26, 2025

Nanoromidepsin, a polymer nanoparticle of the HDAC inhibitor, improves safety and efficacy in models of T-cell lymphoma.

Nanoromidepsin, a polymer nanoparticle of the HDAC inhibitor, improves safety and efficacy in models of T-cell lymphoma.

Journal: Blood

Published: December 13, 2024

Showing 1-12 of 139

Last Updated: 09/26/2026